PureTech News

Press releases
Press Releases - 2022-02-15
Akili
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
Press Releases - 2022-02-10
Other
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Press Releases - 2022-01-31
Gelesis
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
Press Releases - 2022-01-26
Akili
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
Press Releases - 2022-01-14
Other
Gelesis
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
Press Releases - 2022-01-07
Other
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
Press Releases - 2022-01-06
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
Press Releases - 2022-01-05
Gelesis
PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
Press Releases - 2021-12-16
Wholly Owned Pipeline
Other
PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
Press Releases - 2021-12-08
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-300
PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
Displaying 81 - 90 of 356

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH